Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease

NCT00598637 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

650

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease

Interventions

DEVICE: Everolimus-eluting stent (Xience)
DEVICE: Zotarolimus-eluting stent (Endeavor Resolute)

Sponsor

Deutsches Herzzentrum Muenchen

Collaborators

[object Object]